CN113925915A - Borneol gel for treating gout - Google Patents
Borneol gel for treating gout Download PDFInfo
- Publication number
- CN113925915A CN113925915A CN202111110222.5A CN202111110222A CN113925915A CN 113925915 A CN113925915 A CN 113925915A CN 202111110222 A CN202111110222 A CN 202111110222A CN 113925915 A CN113925915 A CN 113925915A
- Authority
- CN
- China
- Prior art keywords
- gel
- borneol
- radix
- gout
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/758—Zanthoxylum, e.g. pricklyash
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8884—Arisaema, e.g. Jack in the pulpit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Abstract
The invention discloses a borneol gout gel, which is prepared from the following raw material medicines and auxiliary materials, wherein the raw material medicines are in the following weight ratio: 80-140g of giant knotweed rhizome, 80-100 g of plantain herb, 30-40g of honeycomb, 3-5g of natural borneol, 10-20g of raw arisaema tuber, 60-90g of mint, 20-100g of pseudo-ginseng, 20-100g of golden nail, 10-50g of corydalis tuber, 30-40g of musk, 3-150g of rhizoma alismatis, 4-210g of medicinal cyathula root, 5-130g of fourstamen stephania root, 10-20g of hawthorn, 5-10g of seaweed, 40-50g of geranium and 20-40g of radix gleditsiae. Compared with the current chemotherapeutic medicine for treatment, the prepared gel is an external medicine, adverse reaction and toxic and side effect are obviously reduced, the gel has good permeability, can directly reach the affected part, has anti-inflammatory and analgesic effects, has obvious treatment effect, obviously improves the medication compliance of patients with gouty arthritis, and improves the life quality of the patients; the gel contains a plurality of medicinal components, effectively solves the source of gouty arthritis, and has the effect of treating both principal and secondary aspects of diseases on the treatment effect of the gouty arthritis.
Description
Technical Field
The invention relates to the technical field of medicines, and particularly relates to borneol gel for treating gout.
Background
At present, colchicine is used as a treatment medicament for gouty arthritis, and Baotan or indomethacin can be selected. The continuous rise of serum uric acid can also be treated by using the carbendazim, and the medicine plays a role in treating the reabsorption of urate by inhibiting renal tubules and is one of effective treatment medicines. If kidney disease is present, allopurines are often the treatment of choice. In the acute stage, steroid injection into joints, joint immobilization and cold compress of local parts can obviously relieve symptoms. However, although the western medicines can rapidly relieve symptoms, the recurrence rate is high, and the disease can rebound after the medicine is stopped, the western medicines must be taken for a long time without interruption, so that the western medicines bring a large economic burden to patients, and the western medicines have large toxic and side effects on the kidney after long-term administration.
Disclosure of Invention
Compared with the current chemotherapeutic medicine for treatment, the borneol gout gel is an external medicine, adverse reaction and toxic and side effects are obviously reduced, the gel has good permeability, can directly reach the affected part, has anti-inflammatory and analgesic effects, has obvious treatment effect, obviously improves the medication compliance of patients with gouty arthritis, and improves the life quality of the patients; the gel contains a plurality of medicinal components, effectively solves the source of gouty arthritis, and has the effect of treating both principal and secondary aspects of diseases on the treatment effect of the gouty arthritis.
In order to solve the technical problems, the invention discloses borneol gout gel which is prepared from the following raw material medicines and auxiliary materials, wherein the raw material medicines are in the following weight ratio: 80-140g of giant knotweed rhizome, 80-100 g of plantain herb, 30-40g of honeycomb, 3-5g of natural borneol, 10-20g of raw arisaema tuber, 60-90g of mint, 20-100g of pseudo-ginseng, 20-100g of golden nail, 10-50g of corydalis tuber, 30-40g of musk, 3-150g of rhizoma alismatis, 4-210g of medicinal cyathula root, 5-130g of fourstamen stephania root, 10-20g of hawthorn, 5-10g of seaweed, 40-50g of geranium and 20-40g of radix gleditsiae.
According to an embodiment of the invention, the auxiliary materials are as follows: 90-120 g of borneol liquid and 500g of medicinal yellow wine.
According to an embodiment of the invention, the ratio of the borneol liquid to the medicinal yellow wine is 1: 5.
According to an embodiment of the invention, the processing method of the borneol gout gel comprises the following specific steps: 1) weighing the following raw materials by weight: rhizoma Polygoni Cuspidati, herba plantaginis, nidus Vespae, Borneolum Syntheticum, rhizoma arisaematis, herba Menthae, Notoginseng radix, squama Manis, rhizoma corydalis, Moschus, Alismatis rhizoma, radix Cyathulae, radix Stephaniae Tetrandrae, fructus crataegi, Sargassum, herba Erodii seu Geranii, and radix Zanthoxyli Spinifolii, pulverizing with a Chinese medicinal pulverizer, and sieving with 100 mesh sieve;
2) uniformly mixing the raw material powder prepared in the step 1 with the auxiliary material medicine, putting the mixture into a pot, standing for 3 to 4 hours, and slightly boiling for 5 to 12 hours;
3) slightly boiling for 5-12 hours, cooling, and cooling in a tank;
4) uniformly stirring the liquid in the tank, and standing for 1-2 months to prepare a stock solution;
5) taking out a proper amount of stock solution and filling the stock solution into a gel bottle.
Compared with the prior art, the application can obtain the following technical effects:
1) compared with the current chemotherapeutic drugs for treatment, the gel is an external drug, the adverse reaction and the toxic and side effect are obviously reduced, the gel has good permeability, can directly reach the affected part, has anti-inflammatory and analgesic effects and obvious treatment effect, the medication compliance of patients with gouty arthritis is obviously improved, and the life quality of the patients is improved; the gel contains a plurality of medicinal components, effectively solves the source of gouty arthritis, and has the effect of treating both principal and secondary aspects of diseases on the treatment effect of the gouty arthritis.
2) The Longnao liquid has the efficacies of dispelling wind and removing dampness, dispersing dampness and relieving pain and the like, is compatible and combined with various other traditional Chinese medicines and is complementary to the other traditional Chinese medicines, achieves the purposes of resisting inflammation and easing pain, and has definite curative effect on gouty arthritis.
Of course, it is not necessary for any one product to achieve all of the above technical results simultaneously in the practice of the present invention.
Detailed Description
The following embodiments will be described in detail with reference to the accompanying examples, so that how to implement the technical means for solving the technical problems and achieving the technical effects of the present application can be fully understood and implemented.
The borneol gel for treating gout is prepared from the following raw material medicines and auxiliary materials, wherein the raw material medicines are in the following weight ratio: 80-140g of giant knotweed rhizome, 80-100 g of plantain herb, 30-40g of honeycomb, 3-5g of natural borneol, 10-20g of raw arisaema tuber, 60-90g of mint, 20-100g of pseudo-ginseng, 20-100g of golden nail, 10-50g of corydalis tuber, 30-40g of musk, 3-150g of rhizoma alismatis, 4-210g of medicinal cyathula root, 5-130g of fourstamen stephania root, 10-20g of hawthorn, 5-10g of seaweed, 40-50g of geranium and 20-40g of radix gleditsiae; the auxiliary materials are prepared from the following components in parts by weight: 90-120 g of borneol liquid and 500g of medicinal yellow wine; the ratio of the borneol liquid to the medicinal yellow wine is 1: 5.
In the embodiment of the invention, the borneol liquid has the effects of dispelling wind, promoting diuresis, dissipating dampness, relieving pain and the like, is compatible and combined with various other traditional Chinese medicines and is complementary to the traditional Chinese medicines, so that the purposes of resisting inflammation and easing pain are achieved, and the borneol liquid has a definite curative effect on gouty arthritis. Compared with the current chemotherapeutic drugs for treatment, the gel is an external drug, the adverse reaction and the toxic and side effect are obviously reduced, the gel has good permeability, can directly reach the affected part, has anti-inflammatory and analgesic effects and obvious treatment effect, the medication compliance of patients with gouty arthritis is obviously improved, and the life quality of the patients is improved; the gel contains a plurality of medicinal components, effectively solves the source of gouty arthritis, and has the effect of treating both principal and secondary aspects of diseases on the treatment effect of the gouty arthritis.
A processing method of borneol gout gel comprises the following specific steps: 1) weighing the following raw materials by weight: rhizoma Polygoni Cuspidati, herba plantaginis, nidus Vespae, Borneolum Syntheticum, rhizoma arisaematis, Camphora, Notoginseng radix, squama Manis, rhizoma corydalis, Moschus, Alismatis rhizoma, radix Cyathulae, radix Stephaniae Tetrandrae, fructus crataegi, Sargassum, herba Erodii seu Geranii, and radix Zanthoxyli Spinifolii, pulverizing with a Chinese medicinal pulverizer, and sieving with 100 mesh sieve; 2) uniformly mixing the raw material powder prepared in the step 1 with the auxiliary material medicine, putting the mixture into a pot, standing for 3 to 4 hours, and slightly boiling for 5 to 12 hours; 3) slightly boiling for 5-12 hours, cooling, and cooling in a tank; 4) uniformly stirring the liquid in the tank, and standing for 1-2 months to prepare a stock solution; 5) taking out a proper amount of stock solution and filling the stock solution into a gel bottle.
The foregoing description shows and describes several preferred embodiments of the present application, but as before, it is to be understood that the application is not limited to the forms disclosed herein, but is not to be construed as excluding other embodiments and is capable of use in various other combinations, modifications, and environments and is capable of changes within the scope of the application as contemplated by the above teachings or as would normally occur to one skilled in the relevant art. And that modifications and variations may be effected by those skilled in the art without departing from the spirit and scope of the application, which is to be protected by the claims appended hereto.
Claims (4)
1. The borneol gel for treating gout is characterized by being prepared from the following raw material medicines and auxiliary materials, wherein the raw material medicines are in the following weight ratio: 80-140g of giant knotweed rhizome, 80-100 g of plantain herb, 30-40g of honeycomb, 3-5g of natural borneol, 10-20g of raw arisaema tuber, 60-90g of mint, 20-100g of pseudo-ginseng, 20-100g of golden nail, 10-50g of corydalis tuber, 30-40g of musk, 3-150g of rhizoma alismatis, 4-210g of medicinal cyathula root, 5-130g of fourstamen stephania root, 10-20g of hawthorn, 5-10g of seaweed, 40-50g of geranium and 20-40g of radix gleditsiae.
2. The borneol gout gel of claim 1, wherein the auxiliary materials are prepared from the following components in parts by weight: 90-120 g of borneol liquid and 500g of medicinal yellow wine.
3. The borneol gout gel of claim 2, wherein the ratio of the borneol liquid to the medicinal yellow wine is 1: 5.
4. The processing method of the borneol gout gel according to any one of claims 1 to 2, characterized by comprising the following specific steps:
1) weighing the following raw materials by weight: rhizoma Polygoni Cuspidati, herba plantaginis, nidus Vespae, Borneolum Syntheticum, rhizoma arisaematis, herba Menthae, Notoginseng radix, squama Manis, rhizoma corydalis, Moschus, Alismatis rhizoma, radix Cyathulae, radix Stephaniae Tetrandrae, fructus crataegi, Sargassum, herba Erodii seu Geranii, and radix Zanthoxyli Spinifolii, pulverizing with a Chinese medicinal pulverizer, and sieving with 100 mesh sieve;
2) uniformly mixing the raw material powder prepared in the step 1 with the auxiliary material medicine, putting the mixture into a pot, standing for 3 to 4 hours, and slightly boiling for 5 to 12 hours;
3) slightly boiling for 5-12 hours, cooling, and cooling in a tank;
4) uniformly stirring the liquid in the tank, and standing for 1-2 months to prepare a stock solution;
5) taking out a proper amount of stock solution and filling the stock solution into a gel bottle.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111110222.5A CN113925915A (en) | 2021-09-23 | 2021-09-23 | Borneol gel for treating gout |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111110222.5A CN113925915A (en) | 2021-09-23 | 2021-09-23 | Borneol gel for treating gout |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113925915A true CN113925915A (en) | 2022-01-14 |
Family
ID=79276474
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111110222.5A Pending CN113925915A (en) | 2021-09-23 | 2021-09-23 | Borneol gel for treating gout |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113925915A (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1709454A (en) * | 2005-07-04 | 2005-12-21 | 北京润德康医药科技有限公司 | Chinese medicine formulation for treating arthrolithiasis, and its preparing method |
| CN103877438A (en) * | 2014-03-13 | 2014-06-25 | 广西中医药大学 | Traditional Chinese medicine preparation for treating gout and production method thereof |
| CN104825554A (en) * | 2015-04-22 | 2015-08-12 | 广州暨南生物医药研究开发基地有限公司 | Gouty arthritis treatment spraying agent |
| CN105412499A (en) * | 2015-12-02 | 2016-03-23 | 天津太平洋制药有限公司 | Medicine for treating gout |
| CN109260338A (en) * | 2018-10-26 | 2019-01-25 | 特医科技（合肥）有限公司 | A kind of gout spray |
| CN109806313A (en) * | 2019-04-03 | 2019-05-28 | 陕西苗三爷昕时业医药管理有限公司 | A kind of externally applied drug for treating gout |
-
2021
- 2021-09-23 CN CN202111110222.5A patent/CN113925915A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1709454A (en) * | 2005-07-04 | 2005-12-21 | 北京润德康医药科技有限公司 | Chinese medicine formulation for treating arthrolithiasis, and its preparing method |
| CN103877438A (en) * | 2014-03-13 | 2014-06-25 | 广西中医药大学 | Traditional Chinese medicine preparation for treating gout and production method thereof |
| CN104825554A (en) * | 2015-04-22 | 2015-08-12 | 广州暨南生物医药研究开发基地有限公司 | Gouty arthritis treatment spraying agent |
| CN105412499A (en) * | 2015-12-02 | 2016-03-23 | 天津太平洋制药有限公司 | Medicine for treating gout |
| CN109260338A (en) * | 2018-10-26 | 2019-01-25 | 特医科技（合肥）有限公司 | A kind of gout spray |
| CN109806313A (en) * | 2019-04-03 | 2019-05-28 | 陕西苗三爷昕时业医药管理有限公司 | A kind of externally applied drug for treating gout |
Non-Patent Citations (1)
| Title |
|---|
| 陈亚萍: "清热通络泄浊汤治疗急性痛风性关节炎45例", 《浙江中西医结合杂志》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1315525C (en) | Chinese traditional medicine for treating breast disease and preparing technique | |
| CN105535448A (en) | Traditional Chinese medicine composition for treating child myasthenia gravis | |
| CN100406045C (en) | Capsule for treating dermatosis | |
| CN101912577B (en) | Medicament for treating rheumatism and rheumatoid disease and preparation process | |
| CN113925915A (en) | Borneol gel for treating gout | |
| CN100409869C (en) | Externally-applied medicinal liquid for treating dermatosis | |
| CN1044091C (en) | Chinese-medicinal capsule for treatment of psoriasis | |
| CN1202852C (en) | Traditional Chinese medicine for treating wind-cold type of common cold and preparation process thereof | |
| CN104998019B (en) | A kind of promoting blood circulation and removing blood stasis, Chinese medicine composition of hemostasis and pain-relieving | |
| CN1186056C (en) | Medicine for treating osteoproliferation | |
| CN1242806C (en) | Medicine | |
| CN1052639C (en) | Traditional Chinese medicine capsule for treating rheumatoid arthritis | |
| CN105012642B (en) | A kind of promoting blood circulation and removing blood stasis, preparation method of the Chinese medicine composition of hemostasis and pain-relieving | |
| CN1454648A (en) | Medicinal liquor for curing rheumatism and traumatic injuries | |
| CN1060663C (en) | Compound Tibet capillary artemisia patent medicine | |
| CN1378861A (en) | Chinese medicine for treating constipation | |
| CN1038477C (en) | Oral liquor for treatment of psoriasis | |
| CN107617098A (en) | One kind treats psoriasic composition | |
| CN101322831B (en) | Chinese medicine powder for treating hydrohystera of milk cattle and preparation method thereof | |
| CN102370806A (en) | Snake medicinal liquor liniment for treating chilblains | |
| CN101612233B (en) | Chinese medicine preparation for detumescence and analgesia | |
| CN104922397B (en) | A kind of promoting blood circulation and removing blood stasis, application of the Chinese medicine composition of hemostasis and pain-relieving | |
| CN1265908A (en) | Cough-relieving medicine | |
| CN105641168A (en) | Medicine for treating viral hepatitis B and viral hepatitis C and preparation method of medicine | |
| CN1232292C (en) | Chinese medicine for treating prostatitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220114 |
|
| RJ01 | Rejection of invention patent application after publication |